U.S. FDA flags risk of heart inflammation after Novavax COVID vaccine
June 3 (Reuters) - U.S. Food and Drug Administration staff said on Friday they were concerned about a possible risk of heart inflammation from Novavax Inc's (NVAX.O) vaccine, even as the company's data showed the vaccine was effective in…